The coronavirus pandemic is bringing about radical changes in global supply chains. But whether companies can draw on the lessons of the present to handle the challenges of future such events is still in question.
The coronavirus pandemic has made it clear that humans make supply chains vulnerable to failure. Greater reliance on automated solutions will be a given from here on out.
COVID-19 is about to put the global trading system through its most dramatic stress-test since World War II, with supply lines for essential food and medical goods entering a critical phase as the pandemic peaks in the U.S. and Europe.
India plans to ramp up production of pharmaceutical ingredients and become an alternative supplier for global drugmakers hit by factory shutdowns in China due to the coronavirus outbreak.
Arena International announced that the Temperature Controlled Logistics in Biopharmaceuticals Conference will be held as a Virtual Experience on Wednesday, April 8, 2020, bringing the coveted platform directly into the homes of our pharmaceutical community. 2020’s Virtual edition will continue to bring engaging networking opportunities and cutting-edge content in cold chain logistics direct to your screen.
Carmakers might seem unlikely candidates to build ventilators for coronavirus victims. But in fact they may be quite well-suited to churn out the highly intricate medical devices that are in critically short supply.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.